Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Novel HIV integrase inhibitors disclosed by Bristol-Myers Squibb

March 5, 2014

New HIV attachment inhibitors designed at Bristol-Myers Squibb

Feb. 26, 2014

Sirenas Marine Discovery receives SBIR grant for its HIV small-molecule therapeutic

Feb. 25, 2014

Bionor Pharma reports data from phase I trial of Vacc-C5

Feb. 25, 2014

Bristol-Myers Squibb discloses new agents for HIV infection

Feb. 24, 2014

HIV vaccine obtains FDA orphan drug status for pediatric HIV/AIDS infection

Feb. 18, 2014

Sedia Biosciences receives phase II funding from NIH for HIV-1 assay

Feb. 13, 2014

New HIV integrase inhibitors patented by Merck & Co.

Feb. 12, 2014

Merck & Co. discloses new HIV prodrugs

Feb. 11, 2014

U.S. Navy approves phase I trial of Multikine in patients with HIV/HPV and perianal warts

Feb. 4, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...